1. Quinidine syncope
- Author
-
Geoffrey Tullett, Donald R. Kahn, Ernest W. Reynolds, and Condon R. VanderArk
- Subjects
Pulmonary and Respiratory Medicine ,Tachycardia ,Quinidine ,medicine.diagnostic_test ,Side effect ,biology ,business.industry ,Syncope (genus) ,Atrial fibrillation ,biology.organism_classification ,medicine.disease ,Anesthesia ,medicine ,Surgery ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Electrocardiography ,Bretylium Compounds ,medicine.drug ,Bretylium Tosylate - Abstract
Quinidine syncope is an unpredictable side effect of quinidine administrateion which has a mortality rate of 11.5 per cent when managed with conventional drugs and direct-current countershock. In 2 patients with quindine syncope, the arrhythmias were effectively controlled within 30 minutes following the slow infusion of 150 mg. of bretylium tosylate. This control is contrasted with 2 cases managed in the conventional manner. Bretylium tosylate is a quaternary amine with unique antifibrillatory properties and appears to have a significant role in the management of these arrhylmias.
- Published
- 1976
- Full Text
- View/download PDF